The p53 activator overcomes resistance to ALK inhibitors by regulating p53-target selectivity in ALK-driven neuroblastomas

Anaplastic lymphoma kinase (ALK) is an oncogenic receptor tyrosine kinase that is activated by gene amplification and mutation in neuroblastomas. ALK inhibitors can delay the progression of ALK-driven cancers, but are of limited use owing to ALK inhibitor resistance. Here, we show that resistance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Makoto, Otomo, Ryo, Matsushima-Hibiya, Yuko, Suzuki, Hidenobu, Nakajima, Ayana, Abe, Naomi, Tomiyama, Arata, Ichimura, Koichi, Matsuda, Koichi, Watanabe, Toshiki, Ochiya, Takahiro, Nakagama, Hitoshi, Sakai, Ryuichi, Enari, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945735/
https://www.ncbi.nlm.nih.gov/pubmed/29760954
http://dx.doi.org/10.1038/s41420-018-0059-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945735/
https://www.ncbi.nlm.nih.gov/pubmed/29760954
http://dx.doi.org/10.1038/s41420-018-0059-0

Ejemplares similares